Schedule 13G ownership disclosure

Kura Oncology Inc

Security class unavailable · CUSIP: 50127T109

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,405,169
Percent of class
5.0900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-23-016317
Form type
SC 13G
Filer
Kura Oncology, Inc.
CIK
CIK 1422143
Filed
Feb 09, 2023
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub